FDA Clears AIRS Medical's AI MRI Tool for Body Composition Analysis
This story is from 2026-10-05. It is preserved in the archive; the latest stories are on the live feed.
AIRS Medical said on October 5, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for SwiftSight Body Composition, its AI-powered quantitative MRI software, with SimonMed Imaging set to be the first customer to deploy it. The Chicago-datelined announcement said the clearance…
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-10-05 16:39 · Unite.AI
FDA Clears AIRS Medical's AI MRI Tool for Body Composition Analysis